Tag: Antengene Corporation
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing...
Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today...